North America In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

NEW YORK, Jan. 23, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

North America In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

http://www.reportlinker.com/p0763031/North-America-In-Vitro-Diagnostics-Market-Outlook-to-2017---Clinical-Chemistry-Genetic-Testing-Haematology-Histology-and-Cytology-Immuno-Chemistry-Infectious-Immunology-and-Microbiology-Culture.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

North America In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Summary

GlobalData's new report, "North America In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture" provides key market data on the North America In Vitro Diagnostics market – Canada and United States. The report provides value (USD million) data for all the market categories – Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Countries covered include Canada and United States.

- Market size and company share data for In Vitro Diagnostics market categories – Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture.

- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2003 to 2010, forecast forward for 7 years to 2017.

- 2010 company shares and distribution shares data for each of the market categories and countries.

- Global corporate-level profiles of key companies operating within the North America In Vitro Diagnostics market..

- Key players covered include Abbott Laboratories, Siemens Healthcare, F. Hoffmann-La Roche Ltd., Beckman Coulter, Inc., Ortho-Clinical Diagnostics Inc., bioMerieux S.A. and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the North America In Vitro Diagnostics competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 10

2 Introduction 11

2.1 What is This Report About? 11

3 In Vitro Diagnostics in North America 12

3.1 In Vitro Diagnostics Cross Country Comparison, USD Actual, 2003-2017 12

3.2 In Vitro Diagnostics, North America, Overall Revenue ($m), USD Actual, 2003-2017 13

3.3 In Vitro Diagnostics, North America, Company share (2009-2010) 21

4 In Vitro Diagnostics In Canada 23

4.1 In Vitro Diagnostics, Canada, Overall Revenue ($m), USD Actual, 2003-2017 23

4.2 In Vitro Diagnostics, Canada, Distribution Share (2009-2010) 29

4.3 In Vitro Diagnostics, Canada, Company share (2009-2010) 33

5 In Vitro Diagnostics In United States 49

5.1 In Vitro Diagnostics, United States, Overall Revenue ($m), USD Actual, 2003-2017 49

5.2 In Vitro Diagnostics, United States Distribution Share (2009-2010) 55

5.3 In Vitro Diagnostics, United States, Company share (2009-2010) 59

6 Overview of Key Companies in North America In Vitro Diagnostics Market 75

6.1 Abbott Laboratories 75

6.2 Siemens Healthcare 76

6.3 F. Hoffmann-La Roche Ltd. 77

6.4 Beckman Coulter, Inc. 78

6.5 Ortho-Clinical Diagnostics Inc. 79

6.6 bioMerieux S.A. 80

6.7 Becton, Dickinson and Company 81

6.8 Bio-Rad Laboratories, Inc. 81

6.9 Alere Inc. 81

6.10 Sysmex Corporation 82

6.11 Qiagen N.V. 82

6.12 Gen-Probe Incorporated 82

6.13 DiaSorin S.p.A 83

6.14 Thermo Fisher Scientific Inc. 83

6.15 Immucor, Inc. 83

6.16 Hologic, Inc. 84

6.17 Phadia AB 84

6.18 Cepheid 84

6.19 Grifols, S.A. 85

6.20 Life Technologies Corporation 85

6.21 PerkinElmer, Inc. 86

6.22 HORIBA, Ltd. 86

6.23 Biomedica Diagnostics Inc. 86

6.24 OraSure Technologies, Inc. 87

7 In Vitro Diagnostics Market Pipeline Products 88

7.1 Clinical Chemisty Market Pipeline Products 88

7.2 Immuno Chemistry Market Pipeline Products 91

7.3 Haematology Market Pipeline Products 94

7.4 Infectious Immunology Market Pipeline Products 97

7.5 Microbiology Culture Market Pipeline Products 100

7.6 Histology and Cytology Market Pipeline Products 102

7.7 Genetic Testing Market Pipeline Products 103

8 Financial Deals Landscape 106

8.1 Merger 106

8.2 Acquisition 108

8.3 Partnerships 178

9 Recent Developments 253

9.1 Strategy And Business Planning 253

9.2 Product News 269

9.3 Legal and Regulatory 344

9.4 Government and Public Interest 347

10 Appendix 419

10.1 Definitions of Markets Covered in the Report 420

10.2 Research Methodology 421

10.3 Secondary Research 421

10.4 Primary Research 422

10.5 Models 422

10.6 Forecasts 423

10.7 Expert Panels 423

10.8 GlobalData Consulting 423

10.9 Currency Conversion 424

10.10 Contact Us 424

10.11 Disclaimer 424

List of Tables

Table 1: In Vitro Diagnostics, Cross Country Comparison, USD Actual, 2003-2017 27

Table 2: In Vitro Diagnostics, North America, Overall Revenue ($m), USD Actual, 2003-2017 29

Table 3: In Vitro Diagnostics, North America, Cross-Category Analysis, 2003-2017 31

Table 4: In Vitro Diagnostics, North America, Overall Revenue ($m), USD Actual, Historic, 2003-2010 33

Table 5: In Vitro Diagnostics, North America, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 35

Table 6: In Vitro Diagnostics, North America, Company share by Revenue ($m), USD Actual, 2009-2010 37

Table 7: In Vitro Diagnostics, Canada, Overall Revenue ($m), USD Actual, 2003-2017 39

Table 8: In Vitro Diagnostics, Canada, Overall Revenue ($m), USD Actual, Historic, 2003-2010 41

Table 9: In Vitro Diagnostics, Canada, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 43

Table 10: Clinical Chemistry, Canada, Distribution Share by Revenue ($m), USD Actual, 2009-2010 44

Table 11: Genetic Testing, Canada, Distribution Share by Revenue ($m), USD Actual, 2009-2010 44

Table 12: Haematology, Canada, Distribution Share by Revenue ($m), USD Actual, 2009-2010 45

Table 13: Histology And Cytology, Canada, Distribution Share by Revenue ($m), USD Actual, 2009-2010 45

Table 14: Immuno Chemistry, Canada, Distribution Share by Revenue ($m), USD Actual, 2009-2010 46

Table 15: Infectious Immunology, Canada, Distribution Share by Revenue ($m), USD Actual, 2009-2010 46

Table 16: Microbiology Culture, Canada, Distribution Share by Revenue ($m), USD Actual, 2009-2010 47

Table 17: In Vitro Diagnostics, Canada, Company share by Revenue ($m), USD Actual, 2009-2010 49

Table 18: Clinical Chemistry, Canada, Company share by Revenue ($m), USD Actual 2009-2010 51

Table 19: Genetic Testing, Canada, Company share by Revenue ($m), USD Actual 2009-2010 53

Table 20: Haematology, Canada, Company share by Revenue ($m), USD Actual 2009-2010 55

Table 21: Histology And Cytology, Canada, Company share by Revenue ($m), USD Actual 2009-2010 57

Table 22: Immuno Chemistry, Canada, Company share by Revenue ($m), USD Actual 2009-2010 59

Table 23: Infectious Immunology, Canada, Company share by Revenue ($m), USD Actual 2009-2010 61

Table 24: Microbiology Culture, Canada, Company share by Revenue ($m), USD Actual 2009-2010 63

Table 25: In Vitro Diagnostics, United States, Overall Revenue ($m), USD Actual, 2003-2017 65

Table 26: In Vitro Diagnostics, United States, Overall Revenue ($m), USD Actual, Historic, 2003-2010 67

Table 27: In Vitro Diagnostics, United States, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 69

Table 28: Clinical Chemistry, United States, Distribution Share by Revenue ($m), USD Actual, 2009-2010 70

Table 29: Genetic Testing, United States, Distribution Share by Revenue ($m), USD Actual, 2009-2010 70

Table 30: Haematology, United States, Distribution Share by Revenue ($m), USD Actual, 2009-2010 71

Table 31: Histology And Cytology, United States, Distribution Share by Revenue ($m), USD Actual, 2009-2010 71

Table 32: Immuno Chemistry, United States, Distribution Share by Revenue ($m), USD Actual, 2009-2010 72

Table 33: Infectious Immunology, United States, Distribution Share by Revenue ($m), USD Actual, 2009-2010 72

Table 34: Microbiology Culture, United States, Distribution Share by Revenue ($m), USD Actual, 2009-2010 73

Table 35: In Vitro Diagnostics, United States, Company share by Revenue ($m), USD Actual, 2009-2010 75

Table 36: Clinical Chemistry, United States, Company share by Revenue ($m), USD Actual 2009-2010 77

Table 37: Genetic Testing, United States, Company share by Revenue ($m), USD Actual 2009-2010 79

Table 38: Haematology, United States, Company share by Revenue ($m), USD Actual 2009-2010 81

Table 39: Histology And Cytology, United States, Company share by Revenue ($m), USD Actual 2009-2010 83

Table 40: Immuno Chemistry, United States, Company share by Revenue ($m), USD Actual 2009-2010 85

Table 41: Infectious Immunology, United States, Company share by Revenue ($m), USD Actual 2009-2010 87

Table 42: Microbiology Culture, United States, Company share by Revenue ($m), USD Actual 2009-2010 89

Table 43: Clinical Chemisty Market Pipeline Products 103

Table 44: Immuno Chemistry Market Pipeline Products 106

Table 45: Haematology Market Pipeline Products 109

Table 46: Infectious Immunology Market Pipeline Products 112

Table 47: Microbiology Culture Market Pipeline Products 115

Table 48: Histology and Cytology Market Pipeline Products 117

Table 49: Genetic Testing Market Pipeline Products 118

Table 50: Transonic Systems Merges With Scisense 121

Table 51: Vivakor Enters Into Memorandum Of Understanding To Merge With Resolution Biomedical 122

Table 52: Pall Corporation To Acquire ForteBio 123

Table 53: Shionogi Acquires Remaining 13% Joint Venture Stake In Ezose Sciences 125

Table 54: Agilent Technologies Completes Acquisition Of BioSystem Development 126

Table 55: Affymetrix To Acquire eBioscience For $330 Million 127

Table 56: AMAG Pharmaceuticals Plans For Sale Of The Company 129

Table 57: Vermillion Completes Acquisition Of Correlogic Systems For $0.4 Million 130

Table 58: Evonik Industries Acquires SurModics Pharmaceuticals From SurModics For $30 Million 131

Table 59: Everist Genomics Acquires Angiologix 133

Table 60: WuXi PharmaTech Acquires Abgent 134

Table 61: OPKO Health Acquires Claros Diagnostics 135

Table 62: Miraca Holdings Completes Acquisition Of Caris Diagnostics From Caris Life Sciences For $725 Million 137

Table 63: Bio-Rad Laboratories Acquires QuantaLife For $162 Million 139

Table 64: Sony Corporation of America Acquires Micronics 140

Table 65: PerkinElmer Completes Acquisition Of Caliper Life Sciences For $600 Million 141

Table 66: Thermo Fisher Scientific Acquires Intrinsic Bioprobes 143

Table 67: EMD Millipore To Acquire Amnis 144

Table 68: Modern Mobility Aids Finalizes Acquisition Of LumiGene Technologies 145

Table 69: OraSure Technologies Completes Acquisition Of DNA Genotek 146

Table 70: Thermo Fisher Scientific Acquires TREK Diagnostic Systems 148

Table 71: Solstas Lab Partners Acquires NextWave Diagnostic Laboratories 150

Table 72: Solstas Lab Partners Acquires Wilmington Pathology Laboratory 151

Table 73: Signal Genetics Acquires DiagnoCure Oncology Laboratories 152

Table 74: Luminex Completes Acquisition Of EraGen Biosciences 153

Table 75: Solstas Lab Partners Acquires Select Diagnostics 155

Table 76: BioMedical Technology Solutions Holdings To Acquire SharpsMD And 2000 Plus Consulting 156

Table 77: Nestle Health Science Completes Acquisition Of Prometheus Laboratories 158

Table 78: Abcam Acquires MitoSciences 160

Table 79: Health Diagnostic Laboratory Acquires Harris Scientific 162

Table 80: EKF Diagnostics Completes Acquisition of Stanbio Laboratory 163

Table 81: PositiveID Completes Acquisition Of MicroFluidic Systems 164

Table 82: Navitar Life Sciences To Acquire Modulation Optics 165

Table 83: Myriad Genetics Acquires Rules-Based Medicine 166

Table 84: Shrink Nanotechnologies To Acquire Nanopoint 168

Table 85: Novelos Therapeutics Acquires Cellectar 170

Table 86: LabCorp Completes Acquisition Of Orchid Cellmark For $85 Million 172

Table 87: ARAMARK Healthcare Acquires ReMedPar From Berkshire Partners 175

Table 88: Quest Diagnostics Completes Acquisition Of Celera 176

Table 89: CerMed International Acquires Viridis Bioscience 179

Table 90: Bruker BioSciences Completes Acquisition Of Michrom Bioresources 180

Table 91: Sparton Acquires Byers Peak 181

Table 92: Becton, Dickinson Completes Acquisition Of Accuri Cytometers 182

Table 93: Alastair John Gray Sells Stake In Phenomenex To Farajollah Farshad Mahjoor 184

Table 94: Trinity Biotech Acquires Phoenix Bio-Tech 185

Table 95: VWR International Acquires AMRESCO 186

Table 96: Sigma-Aldrich Acquires Resource Technology 187

Table 97: Technest Holdings Acquires AccelPath 188

Table 98: Endo Pharmaceuticals To Acquire A Pharmaceutical Company 189

Table 99: Illumina Acquires Epicentre Biotechnologies 190

Table 100: Quest Diagnostics Completes Acquisition Of Athena Diagnostics 191

Table 101: HistoRx Enters Into Licensing Agreement With Yale University 193

Table 102: BioTime Enters Into Distribution Agreement With USCN Life Science 194

Table 103: Critical Path Institute Signs Memorandum Of Understanding With The Hamner Institutes 195

Table 104: Tyrian Diagnostics Enters Into Distribution Agreement With NeoClone 196

Table 105: Global BioDiagnostics Extends Co-Development Agreement With Foundation for Innovative New Diagnostics 197

Table 106: Sony DADC Enters Into Co-Development Agreement With Axela 198

Table 107: Lineagen Enters Into Co-Development Agreement With Fast Forward 199

Table 108: Pathogenetix Enters Into Co-Development Agreement With Sagentia 200

Table 109: Bio-Rad Expands Co-Marketing Agreement With Siemens Medical 201

Table 110: Ezose Sciences Enters Into Co-Development Agreement With Merck 202

Table 111: Genome British Columbia Enters Into Co-Development Agreement With Genome Canada 203

Table 112: Fluxion Biosciences Enters Into Distribution Agreement With EMD Millipore 204

Table 113: Roche Enters Into Technology Integration Agreement With Labcyte 205

Table 114: Sony DADC BioSciences Enters Into Co-Development Agreement With Maven Biotechnologies 206

Table 115: Abbott Laboratories Expands Its Co-Development Agreement With GlaxoSmithKline Biologicals 207

Table 116: Olink Bioscience Enters Into Distribution Agreement With Bethyl Laboratories 208

Table 117: SuperNova Diagnostics Enters Into Co-Development Agreement With Concile 209

Table 118: OncoSec Medical Enters Into Research Agreement With Serametrix 210

Table 119: Bruker Enters Into Co-Development Agreement With Lawrence Berkeley National Laboratory 211

Table 120: Dako Enters Into Co-Development Agreement With Bristol-Myers 213

Table 121: Transgenomic Enters Into Distribution Agreement With ScreenCell 214

Table 122: Horizon Discovery Enters Into Co-Development Agreement With Promega 215

Table 123: Stemina Biomarker Discovery Enters Into Co-Development Agreement With ILS 216

Table 124: Psyche Systems Enters Into Technology Integration Agreement With Aperio Technologies 217

Table 125: Life Technologies Enters Into Co-Development Agreement With GlaxoSmithKline Biologicals 218

Table 126: PrognosDx Health Entetrs Into Co-Development Agreement With Accium BioSciences 219

Table 127: The Molecular Sciences Forms Joint Venture With VTT Technical Research 220

Table 128: DxTerity Diagnostics Enters Into Technology Integration Agreement With Caliper Life Sciences 221

Table 129: Gold Standard Diagnostics Extends Distribution Agreement With Fujirebio Diagnostics 222

Table 130: New England Biolabs Enters Into Co-Marketing Agreement With Rubicon Genomics 223

Table 131: WILEX Enters Into Co-Marketing Agreement With ALPCO Diagnostics 224

Table 132: Illumina Enters Into Co-Development Agreement With University Of North Texas Health Science Center 225

Table 133: Warnex Medical Laboratories Enters Into Distribution Agreement With deCODE genetics 226

Table 134: Absorption Systems Enters Into Co-Development Agreement With Temple University And Washington State University 227

Table 135: Oasis Diagnostics Enters Into Licensing Agreement With Two Researchers 228

Table 136: Bioo Scientific Enters Into Co-Development Agreement With JungWoo 229

Table 137: Accelr8 Technology Amends Licensing Agreement With SCHOTT 230

Table 138: Warnex PRO-DNA Enters Into Co-Development Agreement With National Research Council of Canada 231

Table 139: Orion Genomics Enters Into Licensing Agreement With QIAGEN 232

Table 140: Quantum Materials Enters Into Technology Integration Agreement With Nanoaxis 233

Table 141: Warnex Enters Into Licensing Agreement With Sorenson Forensics 234

Table 142: RedHill Biopharma Enters Into Licensing Agreement With UCF Research Foundation 235

Table 143: SuviCa Enters Into Licensing Agreement With University of Colorado 236

Table 144: Polymedco Enters Into Distribution Agreement With Cardinal Health 237

Table 145: Universal Biosensors Enters Into Co-Development Agreement With Siemens Healthcare Diagnostics 238

Table 146: LI-COR Biosciences Enters Into Licensing Agreement With Johns Hopkins University 239

Table 147: QIAGEN Enters Into Co-Development Agreement With Eli Lilly 240

Table 148: Sun Yat-sen University Enters Into Co-Development Agreement With BioDesign Institute 241

Table 149: Lumora Enters Into Licensing Agreement With 3M 242

Table 150: NuGEN Technologies Enters Into Co-Development Agreement With Advanced Liquid Logic And Broad Institute 243

Table 151: Biocept Enters Into Co-Marketing Agreement With Clarient 245

Table 152: Roche Enters Into Distribution Agreement With PerkinElmer 246

Table 153: Quanterix Enters Into Co-Development Agreement With STRATEC Biomedical 247

Table 154: DNA Diagnostics Center Enters Into Licensing Agreement 248

Table 155: Pronexus Enters Into Technology Integration Agreement With RealityCorp 249

Table 156: Carl Zeiss Enters Into Licensing Agreement With Prior Scientific 250

Table 157: EPIC Enters Into Distribution Agreement With Micro Imaging Technology 251

Table 158: BD Diagnostics Enters Into Co-Development Agreement With Lab21 252

Table 159: Procognia Enters Into Co-Development Agreement With Caerus Discovery 253

Table 160: BioMarCare Technologies Enters Into Co-Development Agreement With Ariadne 254

Table 161: Hycor Biomedical Signs Licensing Agreement With Axis-Shield 255

Table 162: Thermo Fisher Scientific Enters Into Licensing Agreement With Alere 256

Table 163: Quanterix Enters Into Co-Development Agreement With Sony DADC 257

Table 164: Canon U.S. Life Sciences Enters Into Co-Development Agreement With The University of Maryland 258

Table 165: Mayo Medical Laboratories Enters Into Licensing Agreement With Qiagen 259

Table 166: Rhoen-Klinikum Enters Into Co-Development Agreement With Siemens 260

Table 167: Proteome Sciences Enters Into Collaboration With Buck Institute 261

Table 168: Stratos Product Development Enters Into Co-Development Agreement With Response Biomedical 262

Table 169: Gold Standard Diagnostics Enters Into Distribution Agreement With Fujirebio Diagnostics 263

Table 170: Roche NimbleGen Enters Into Co-Marketing Agreement With Caliper Life Sciences 264

Table 171: Clinical Genomics Extends Its Licensing Agreement With Quest Diagnostics 265

Table 172: LaserGen Enters Into Co-Development Agreement With National Instruments 266

Table 173: Proteome Sciences Enters Into Co-Development Agreement With H. Lee Moffitt Cancer Center 267

Table 174: USD to Local Currency, North America, Average Exchange Rate 2003-2010 439

List of Figures

Figure 1: In Vitro Diagnostics, Cross Country Comparison, USD Actual, 2003-2017 27

Figure 2: In Vitro Diagnostics, North America, Overall Revenue ($m), USD Actual, 2003-2017 28

Figure 3: In Vitro Diagnostics, North America, Cross-Category Analysis, 2003-2017 30

Figure 4: In Vitro Diagnostics, North America, Overall Revenue ($m), USD Actual, Historic, 2003-2010 32

Figure 5: In Vitro Diagnostics, North America, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 34

Figure 6: In Vitro Diagnostics, North America, Company share (%), 2010 36

Figure 7: In Vitro Diagnostics, Canada, Overall Revenue ($m), USD Actual, 2003-2017 38

Figure 8: In Vitro Diagnostics, Canada, Overall Revenue ($m), USD Actual, Historic, 2003-2010 40

Figure 9: In Vitro Diagnostics, Canada, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 42

Figure 10: In Vitro Diagnostics, Canada, Company share (%), 2010 48

Figure 11: Clinical Chemistry, Canada, Company share (%), 2010 50

Figure 12: Genetic Testing, Canada, Company share (%), 2010 52

Figure 13: Haematology, Canada, Company share (%), 2010 54

Figure 14: Histology And Cytology, Canada, Company share (%), 2010 56

Figure 15: Immuno Chemistry, Canada, Company share (%), 2010 58

Figure 16: Infectious Immunology, Canada, Company share (%), 2010 60

Figure 17: Microbiology Culture, Canada, Company share (%), 2010 62

Figure 18: In Vitro Diagnostics, United States, Overall Revenue ($m), USD Actual, 2003-2017 64

Figure 19: In Vitro Diagnostics, United States, Overall Revenue ($m), USD Actual, Historic, 2003-2010 66

Figure 20: In Vitro Diagnostics, United States, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 68

Figure 21: In Vitro Diagnostics, United States, Company share (%), 2010 74

Figure 22: Clinical Chemistry, United States, Company share (%), 2010 76

Figure 23: Genetic Testing, United States, Company share (%), 2010 78

Figure 24: Haematology, United States, Company share (%), 2010 80

Figure 25: Histology And Cytology, United States, Company share (%), 2010 82

Figure 26: Immuno Chemistry, United States, Company share (%), 2010 84

Figure 27: Infectious Immunology, United States, Company share (%), 2010 86

Figure 28: Microbiology Culture, United States, Company share (%), 2010 88

Figure 29: Abbott Laboratories, Company Share (%), North America In Vitro Diagnostics Market, 2010 90

Figure 30: Siemens Healthcare, Company Share (%), North America In Vitro Diagnostics Market, 2010 91

Figure 31: F. Hoffmann-La Roche Ltd., Company Share (%), North America In Vitro Diagnostics Market, 2010 92

Figure 32: Beckman Coulter, Inc., Company Share (%), North America In Vitro Diagnostics Market, 2010 93

Figure 33: Ortho-Clinical Diagnostics Inc., Company Share (%), North America In Vitro Diagnostics Market, 2010 94

Figure 34: bioMerieux S.A., Company Share (%), North America In Vitro Diagnostics Market, 2010 95

Companies mentioned

Abbott Laboratories

Siemens Healthcare

F. Hoffmann-La Roche Ltd.

Beckman Coulter, Inc.

Ortho-Clinical Diagnostics Inc.

bioMerieux S.A.

Becton, Dickinson and Company

Bio-Rad Laboratories, Inc.

Alere Inc.

Sysmex Corporation

Qiagen N.V.

Gen-Probe Incorporated

DiaSorin S.p.A

Thermo Fisher Scientific Inc.

Immucor, Inc.

Hologic, Inc.

Phadia AB

Cepheid

Grifols, S.A.

Life Technologies Corporation

PerkinElmer, Inc.

HORIBA, Ltd.

Biomedica Diagnostics Inc.

OraSure Technologies, Inc.

To order this report:

In Vitro Diagnostic Industry: North America In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

More  Market Research Report

Check our  Industry Analysis and Insights

CONTACT
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker